Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting integrin pathways: mechanisms and advances in therapy
Xiaocong Pang, Xu He, Zhiwei Qiu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 442

Showing 1-25 of 442 citing articles:

NF-κB in biology and targeted therapy: new insights and translational implications
Qing Guo, Yizi Jin, Xinyu Chen, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 394
Exploring treatment options in cancer: Tumor treatment strategies
Beilei Liu, Hongyu Zhou, Licheng Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 155
Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets
Joshua S. Fleishman, Sunil Kumar
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 70
Targeting strategies for bone diseases: signaling pathways and clinical studies
Hao Xu, Wentao Wang, Xin Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 60
Cancer metastasis: Molecular mechanisms and clinical perspectives
Sameer Ullah Khan, Kaneez Fatima, Fayaz Malik, et al.
Pharmacology & Therapeutics (2023) Vol. 250, pp. 108522-108522
Closed Access | Times Cited: 60
Integrin signaling in cancer: bidirectional mechanisms and therapeutic opportunities
Siyi Li, Chibuzo Sampson, Changhao Liu, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 52
RGD peptide in cancer targeting: Benefits, challenges, solutions, and possible integrin–RGD interactions
Hossein Javid, Mahsa Akbari Oryani, Nastaran Rezagholinejad, et al.
Cancer Medicine (2024) Vol. 13, Iss. 2
Open Access | Times Cited: 52
Therapeutic advances of targeting receptor tyrosine kinases in cancer
Ciprian Tomuleasa, Adrian Bogdan Țigu, Raluca Munteanu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 23
Matrix stiffness affects tumor-associated macrophage functional polarization and its potential in tumor therapy
Jiaqiang Xiong, Rourou Xiao, Jiahui Zhao, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 19
Extracellular matrix dynamics: A key regulator of cell migration across length-scales and systems
Dharma Pally, Alexandra Naba
Current Opinion in Cell Biology (2024) Vol. 86, pp. 102309-102309
Closed Access | Times Cited: 18
Dietary factors and their influence on immunotherapy strategies in oncology: a comprehensive review
Aleksandra Golonko, Tomasz Pienkowski, Renata Świsłocka, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 18
Hallmarks of cancer resistance
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109979-109979
Open Access | Times Cited: 18
The role and regulation of integrins in cell migration and invasion
Megan R. Chastney, Jasmin Kaivola, Veli‐Matti Leppänen, et al.
Nature Reviews Molecular Cell Biology (2024)
Closed Access | Times Cited: 17
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 10
Cyclin-dependent protein kinases and cell cycle regulation in biology and disease
Ilenia Pellarin, Alessandra Dall’Acqua, Andrea Favero, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 7
Electrically Active Biomaterials for Stimulation and Regeneration in Tissue Engineering
Jinyoung Park, Gülşah Erel‐Akbaba, Nidhi Sharma, et al.
Journal of Biomedical Materials Research Part A (2025) Vol. 113, Iss. 1
Closed Access | Times Cited: 2
Clinical Evaluation of68Ga-FAPI-RGD for Imaging of Fibroblast Activation Protein and Integrin αvβ3in Various Cancer Types
Liang Zhao, Xuejun Wen, Weizhi Xu, et al.
Journal of Nuclear Medicine (2023) Vol. 64, Iss. 8, pp. 1210-1217
Open Access | Times Cited: 34
The challenges and opportunities of αvβ3-based therapeutics in cancer: From bench to clinical trials
Yanlun Gu, Bingqi Dong, Xu He, et al.
Pharmacological Research (2023) Vol. 189, pp. 106694-106694
Open Access | Times Cited: 29
Osteopontin as a Biomarker in Chronic Kidney Disease
Satyesh K. Sinha, Michael Mellody, Maria Beatriz Carpio, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1356-1356
Open Access | Times Cited: 29
The characteristics and the multiple functions of integrin β1 in human cancers
Li Sun, Shuwei Guo, Yiping Xie, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 24
A Narrative Review of Cytokine Networks: Pathophysiological and Therapeutic Implications for Inflammatory Bowel Disease Pathogenesis
Marek Vébr, Renata Pomahačová, Josef Sýkora, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3229-3229
Open Access | Times Cited: 24
Macro CD5L+ deteriorates CD8+T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma
Jia‐Cheng Lu, Lei‐Lei Wu, Yining Sun, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 15
Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy
Shashi Gujar, Jonathan Pol, K. Vishnupriyan, et al.
Nature Protocols (2024) Vol. 19, Iss. 9, pp. 2540-2570
Closed Access | Times Cited: 14
Targeting focal adhesion kinase (FAK) for cancer therapy: FAK inhibitors, FAK-based dual-target inhibitors and PROTAC degraders
Ming Yang, Hua Xiang, Guoshun Luo
Biochemical Pharmacology (2024) Vol. 224, pp. 116246-116246
Closed Access | Times Cited: 13
Measurement of IFN-γ and IL-2 for the assessment of the cellular immunity against SARS-CoV-2
Guillem Safont, Raquel Villar-Hernández, Daria Smalchuk, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top